Vedolizumab safety in pregnancy and newborn outcomes
- PMID: 28073891
- DOI: 10.1136/gutjnl-2016-313444
Vedolizumab safety in pregnancy and newborn outcomes
Keywords: CROHN'S DISEASE; PHARMACOTHERAPY; ULCERATIVE COLITIS.
Conflict of interest statement
Competing interests: MJ, JK and DCB have served as paid speakers on medical education events supported by and/or scientific advisors to Takeda, manufacturer of vedolizumab.
Comment on
-
The safety of vedolizumab for ulcerative colitis and Crohn's disease.Gut. 2017 May;66(5):839-851. doi: 10.1136/gutjnl-2015-311079. Epub 2016 Feb 18. Gut. 2017. PMID: 26893500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical